The impact of weight loss during neoadjuvant chemotherapy on postoperative infectious complications and prognosis in patients with esophageal cancer: exploratory analysis of OGSG1003.
Shu AoyamaMasaaki MotooriMakoto YamasakiOsamu ShiraishiHiroshi MiyataMotohiro HiraoAtsushi TakenoKeijiro SugimuraTomoki MakinoKoji TanakaTakuya HamakawaKotaro YamashitaYutaka KimuraKazumasa FujitaniTakushi YasudaMasahiko YanoYuichiro DokiPublished in: Esophagus : official journal of the Japan Esophageal Society (2022)
Severe weight loss during neoadjuvant chemotherapy was an independent risk factor for postoperative infectious complications. Weight maintenance during neoadjuvant chemotherapy may reduce the incidence of postoperative infectious complications.
Keyphrases
- neoadjuvant chemotherapy
- weight loss
- locally advanced
- risk factors
- patients undergoing
- bariatric surgery
- lymph node
- sentinel lymph node
- roux en y gastric bypass
- gastric bypass
- squamous cell carcinoma
- rectal cancer
- body mass index
- radiation therapy
- physical activity
- type diabetes
- adipose tissue
- metabolic syndrome
- glycemic control
- body weight
- skeletal muscle